Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Watching Imunon, Zacks Small-Cap Research Sets $17 Price Valuation

Watching Imunon, Zacks Small-Cap Research Sets $17 Price Valuation

https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_11302022_IMNN_Bautz.pdf

byBenzinga Newsdesk

November 30, 2022

1 minute read

https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_11302022_IMNN_Bautz.pdf

Why Borqs Technologies Stock Is Trading Higher Today

By Nabaparna Bhattacharya

July 6, 10:18 AM

Borqs Technologies, Inc. (NASDAQ: BRQS), together with SkyCentrics, launched the next generation CTA-2045

BRQS

BTIG Maintains Buy on Revolve Gr, Lowers Price Target to $50

By Benzinga Newsdesk

July 21, 9:39 AM

BTIG analyst Camilo Lyon maintains Revolve Gr (NYSE:RVLV) with a Buy and lowers the price target from $66 to $50.

RVLV

Hologic Announces FDA Clearance Of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay

By Happy Mohamed

May 19, 8:09 AM

Multiplexed Respiratory Test Now Available in the U.S. With New RespDirect Collection Kit Hologic Inc. (NASDAQ:HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the

HOLX

Biden Says US ‘All In On Africa’s Future’ As Rivalry With Xi Jinping’s China Heats Up

By Navdeep Yadav

December 15, 12:34 AM

President Joe Biden on Wednesday at the U.S.-Africa Business Forum told his 49 African counterparts that the U.S.…

CSCO

Watching Imunon, Zacks Small-Cap Research Sets $17 Price Valuation

Related Posts

Why Borqs Technologies Stock Is Trading Higher Today

BTIG Maintains Buy on Revolve Gr, Lowers Price Target to $50

Hologic Announces FDA Clearance Of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay

Biden Says US ‘All In On Africa’s Future’ As Rivalry With Xi Jinping’s China Heats Up